Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 451 of 5804
-
One shot before surgery: could early immunotherapy stop melanoma in its tracks?
Disease control Recruiting nowThis study, called NeoSenti, is exploring whether giving one dose of the immunotherapy drug pembrolizumab before surgery can help the immune system fight melanoma more effectively. The study includes adults with high-risk melanoma who do not show any signs of the cancer having sp…
Phase: PHASE2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug shows promise for rapid symptom relief in Early-Stage muscle disease
Disease control Recruiting nowThe main purpose of this study is to measure how well adults with new-onset gMG (which means they've had generalized disease signs and/or symptoms for less than 1 year) respond to treatment with efgartigimod PH20 SC. The study consists of a treatment period of 51 weeks. The study…
Phase: PHASE4 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New heart zapping technique could be safer for AF patients
Disease control Recruiting nowAtrial fibrillation (AF) is one of the most common arrhythmias in clinical practice. As of 2019, there were approximately 59.7 million patients with AF worldwide, including atrial flutter (AF). Atrial fibrillation can significantly increase the risks of stroke, thromboembolism an…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New eye drug EYE103 takes on standard treatment for Diabetes-Related vision loss
Disease control OngoingEYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME). In the first year, all 3 treatment groups will be treated ev…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a simple hormone shield kidneys after liver transplant?
Disease control Recruiting nowLiver transplantation (LT) is a high-risk surgery for hemodynamic instability and haemorrhagic shock with a high-risk of acute kidney injury (AKI). Indeed, the incidence of post-transplant AKI exceeds 50% in some series with 15% of patients requiring renal replacement therapy. Ac…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New antibody drug aims to ease double vision and bulging eyes in thyroid disease
Disease control Recruiting nowThyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO…
Phase: PHASE4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:04 UTC
-
New hope for advanced liver cancer: particle beam plus immunotherapy trial launches
Disease control Recruiting nowIn the present study, we aim to investigate the efficacy and safety of concurrent therapy of Immunotherapy based combination therapy and Radiotherapy in patients with advanced HCC showing macrovascular invasion.
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
At-Home sample test could spot uterine cancer early
Diagnosis Recruiting nowThe goal of this observational case-control study is to investigate the use of DNA-methylation testing in patient-collected urine and vaginal samples to detect endometrial cancer. The study aims to answer the following questions: * Can DNA methylation testing in vaginal and full…
Sponsor: University of Aarhus • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
Could a common drug stop a rare liver disease from returning after transplant?
Prevention Recruiting nowThis study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurrence of primary sclerosing cholangitis after liver transplantation, compared with a historical control cohort that was not treated with
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
New combo therapy aims to tame thyroid eye disease
Disease control Recruiting nowThyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO…
Phase: PHASE4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Glow-in-the-Dark dye could help surgeons find hidden tumors in kids
Diagnosis Recruiting nowThis phase III trial studies how well pafolacianine works for identifying cancerous lesions in children and adolescent patients with primary solid tumors or solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic). Pafola…
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New Antibody-Drug combo takes aim at Hard-to-Treat ovarian cancer
Disease control Recruiting nowResearchers are looking for other ways to treat relapsed high-grade serous ovarian cancer. Relapsed means the cancer came back after treatment. High-grade means the cancer cells grow and spread quickly. Serous means the cancer started in the cells that cover the ovaries, the lini…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail aims to stop deadly transplant complication
Disease control Recruiting nowThe purpose of this study is to test whether the combination of the drugs called tacrolimus (Tac), methotrexate (MTX) and new dosing strategy of another drug called (rabbit Anti-thymocyte Globulin \[ATG\]) will help prevent the development and/or improve severity of acute and/or …
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New radioactive beads aim to outperform standard liver cancer therapy
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy and safety of NRT6003 Injection compared to cTACE in patients with unresectable HCC.
Phase: PHASE3 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New bladder cancer combo shows promise in Pre-Surgery trial
Disease control Recruiting nowThe purpose of this Phase II, open-label, multicenter, randomized controlled study is to evaluate the efficacy and safety of Enfortumab Vedotin in combination with Toripalimab compared to Gemcitabine plus Cisplatin. This regimen is evaluated as a neoadjuvant treatment for patient…
Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill for psoriasis shows promise in large trial
Disease control OngoingThe main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to severe plaque psoriasis.
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood platelet RNA test could revolutionize ovarian cancer detection
Diagnosis Recruiting nowThe purpose of the SENTRY (Stability Enhanced Transcriptional Analytics) Study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses ovarian cancer. Using retrospective data, the investigators have developed an appr…
Sponsor: University of Utah • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Could carbon dioxide replace contrast dye to save kidneys?
Disease control Recruiting nowThe primary objective of the trial is to evaluate if an iodinated contrast medium sparing strategy using automated Carbon Dioxide (CO2) Injection prevents Major Adverse Kidney Events up to 90 days (MAKE90) in patients at moderately elevated risk for contrast-associated acute kidn…
Phase: PHASE3 • Sponsor: University of Leipzig • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Weight-Loss drug semaglutide takes on atrial fibrillation in new trial
Disease control Recruiting nowThe goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard A…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a higher radiation dose help older brain cancer patients live longer?
Disease control Recruiting nowGlioblastoma (GBM) is an aggressive malignancy of the central nervous system. Older adults with GBM have a unique constellation of medical, psychosocial, and supportive care needs. To address these challenges, prior work has evaluated the feasibility of hypofractionation, a treat…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC